REFERENCES
- Roberts SE, Williams JG, Meddings D, et al. Incidence and case fatality for acute pancreatitis in England: geographical variation, social deprivation, alcohol consumption and aetiology—a record linkage study. Aliment Pharmacol Ther. 2008;28:931–41.
- Roberts SE, Akbari A, Thorne K, A.et al. The incidence of acute pancreatitis: impact of social deprivation, alcohol consumption, seasonal and demographic factors. Aliment Pharmacol Ther. 2013;38:539–548.
- Gluszek S, Koziel D. Prevalence and progression of acute pancreatitis in the swietokrzyskie voivodeship population. Pol Przegl Chir. 2012;84:618–25.
- Phillip V, Steiner JM, Algül H. Early phase of acute pancreatitis: assessment and management. World J Gastrointest Pathophysiol. 2014;5:158–68.
- Lundberg AH, Granger DN, Russell J, et al. Quantitative measurement of P- and E-selectin adhesion molecules in acute pancreatitis: correlation with distant organ injury. Ann Surg. 2000;231:213–22.
- Lin WC, Chen CW, Huang YW, et al. Kallistatin protects against sepsis-related acute lung injury via inhibiting inflammation and apoptosis. Sci Rep. 2015;5:12463.
- Wong LL, Tsai HH. Prevention of post-ERCP pancreatitis.World J Gastrointest Pathophysiol. 2014;5:1–10.
- Keceli M, Kucuk C, Sozuer E, et al. The effect of interleukin-10 on acute pancreatitis induced by cerulein in a rat experimental model.J Invest Surg. 2005;18:7–12.
- Onur E, Paksoy M, Baca B, et al. Hyperbaric oxygen and N-acetylcysteine treatment in L-arginine-induced acute pancreatitis in rats. J Invest Surg. 2012;25:20–8.
- Lampropoulos P, Lambropoulou M, Papalois A, et al. The role of apigenin in an experimental model of acute pancreatitis.J Surg Res. 2013;183:129–37.
- Di Carlo G, Mascolo N, Izzo AA, et al. Flavonoids: old and new aspects of a class of natural therapeutic drugs. Life Sci 1999;65:337–53.
- Kim HP, Son KH, Chang HW, et al. Anti-inflammatory plant flavonoids and cellular action mechanisms. J Pharmacol Sci. 2004;96:229–45.
- Garcıa-Lafuente A, Guillamon E, Villares A, et al. Flavonoids as anti-inflammatory agents: implications in cancer and cardiovascular disease. Inflamm Res 2009;58:537–52.
- Park JA, Ha SK, Kang TH, et al. Protective effect of apigenin on ovariectomy-induced bone loss in rats. Life Sci 2008;82:1217–23.
- Barrera P, Joosten LA, den Broeder AA, et al. Effects of treatment with a fully human anti-tumour necrosis factor alpha monoclonal antibody on the local and systemic homeostasis of interleukin 1 and TNF alpha in patients with rheumatoid arthritis. Ann Rheum Dis. 2001;60:660–9.
- Shukla S, Gupta S. Apigenin: a promising molecule for cancer prevention. Pharm Res. 2010;27:962–78.
- Patel D, Shukla S, Gupta S. Apigenin and cancer chemoprevention: progress, potential and promise (review). Int J Oncol. 2007;30:233–45.
- Birt DF, Walker B, Tibbels MG, et al. Anti-mutagenesis and anti-promotion by apigenin, robinetin and indole-3-carbinol. Carcinogenesis. 1986;7:959–63.
- Liang YC, Huang YT, Tsai SH, et al. Suppression of inducible cyclooxygenase and inducible nitric oxide synthase by apigenin and related flavonoids in mouse macrophages. Carcinogenesis. 1999;20:1945–52.
- Kawai M, Hirano T, Higa S, et al. Flavonoids and related compounds as anti-allergic substances. Allergol Int. 2007;56:113–23.
- Choi JS, Choi YJ, Park SH, et al. Flavones mitigate tumor necrosis factor-alpha-induced adhesion molecule upregulation in cultured human endothelial cells: role of nuclear factor-kappa B. J Nutr. 2004;134:1013–9.
- Bito T, Roy S, Sen CK, et al. Flavonoids differentially regulate IFN gamma-induced ICAM-1 expression in human keratinocytes: molecular mechanisms of action. FEBS Lett. 2002;520:145–52.
- Joo M, Kim HS, Kwon TH, et al. Anti-inflammatory effects of flavonoids on TNBS-induced colitis of rats. Korean J Physiol Pharmacol. 2015;19:43–50.
- Li KC, Ho YL, Hsieh WT, et al. Apigenin-7-glycoside prevents LPS-induced acute lung injury via downregulation of oxidative enzyme expression and protein activation through inhibition of MAPK phosphorylation. Int J Mol Sci. 2015;161:1736–54.